Article

Reimbursement and Launch Strategy

Payer perspective strengthens a product’s value story

A mid-size biotech wanted to launch its first infused hematology product into a competitive disease state. Xcenda conducted a reimbursement landscape assessment and gathered insights from nearly 100 pharmacy and medical directors of the Managed Care Network. Using the results to inform pricing strategy and product value story, Xcenda helped the client develop a robust suite of patient, provider and payer resources and services to facilitate a launch free of reimbursement or access hurdles.

Read the case study

Available in English only

Related resources

Article

RAPS Convergence 2025: Transparency, Trust, and Resilience in Regulatory Science

Learn more

Article

The complex path to meeting promotional materials requirements in Europe

Learn more

Article

The critical role of industry in the PMS and master data

Learn more

Cencora.com is providing automated translations to assist in reading the website in languages other than English. For these translations, reasonable efforts have been made to provide an accurate translation, however, no automated translation is perfect nor is it intended to replace human translators. These translations are provided as a service to users of Cencora.com and are provided "as is." No warranty of any kind, either expressed or implied, is made as to the accuracy, reliability, or correctness of any of these translations made from English into any other language. Some content (such as images, videos, Flash, etc.) may not be accurately translated due to the limitations of the translation software.

Any discrepancies or differences created in translating this content from English into another language are not binding and have no legal effect for compliance, enforcement, or any other purpose. If any errors are identified, please contact us. If any questions arise related to the accuracy of the information contained in these translations, please refer to the English version of the page.